EXELA PHARMA SCIENCES, LLC v. CORNERSTONE THERAPEUTICS INC., 5:13-CV-111-RLV-DCK. (2013)
Court: District Court, W.D. North Carolina
Number: infdco20130909834
Visitors: 5
Filed: Sep. 05, 2013
Latest Update: Sep. 05, 2013
Summary: ORDER DAVID C. KEESLER, Magistrate Judge. THIS MATTER IS BEFORE THE COURT on the "Application For Admission To Practice Pro Hac Vice " (Document No. 20) filed by Melanie Black Dubis, concerning Nicholas F. Giove on September 4, 2013. Mr. Nicholas F. Giove seeks to appear as counsel pro hac vice for Defendants Cornerstone Therapeutics, Inc., Cornerstone BioPharma, Inc. and EKR Therapeutics, LLC. Upon review and consideration of the motion, which was accompanied by submission of the necessa
Summary: ORDER DAVID C. KEESLER, Magistrate Judge. THIS MATTER IS BEFORE THE COURT on the "Application For Admission To Practice Pro Hac Vice " (Document No. 20) filed by Melanie Black Dubis, concerning Nicholas F. Giove on September 4, 2013. Mr. Nicholas F. Giove seeks to appear as counsel pro hac vice for Defendants Cornerstone Therapeutics, Inc., Cornerstone BioPharma, Inc. and EKR Therapeutics, LLC. Upon review and consideration of the motion, which was accompanied by submission of the necessar..
More
ORDER
DAVID C. KEESLER, Magistrate Judge.
THIS MATTER IS BEFORE THE COURT on the "Application For Admission To Practice Pro Hac Vice" (Document No. 20) filed by Melanie Black Dubis, concerning Nicholas F. Giove on September 4, 2013. Mr. Nicholas F. Giove seeks to appear as counsel pro hac vice for Defendants Cornerstone Therapeutics, Inc., Cornerstone BioPharma, Inc. and EKR Therapeutics, LLC. Upon review and consideration of the motion, which was accompanied by submission of the necessary fee, the Court will grant the motion.
IT IS, THEREFORE, ORDERED that in accordance with Local Rule 83.1, the "Application For Admission To Practice Pro Hac Vice" (Document No. 20) is GRANTED. Mr. Nicholas F. Giove is hereby admitted pro hac vice to represent Defendants Cornerstone Therapeutics, Inc., Cornerstone BioPharma, Inc. and EKR Therapeutics, LLC.
SO ORDERED.
Source: Leagle
